Literature DB >> 3004028

MPLV: a retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice.

F Wendling, P Varlet, M Charon, P Tambourin.   

Abstract

A novel murine retrovirus complex was derived from the in vivo passage of a molecularly cloned Friend ecotropic helper virus. The virus isolate, myeloproliferative leukemia virus (MPLV), causes an acute (2-3 weeks) and generalized myeloproliferative disorder in adult mice. All strains of mice examined, including the C57BL/6J strain, developed the acute syndrome. This syndrome is characterized by a rapid hepatosplenomegaly, no thymus or lymph node involvement, granulocytosis, thrombocytosis, and erythroblastosis leading to polycythemia. The most prominent feature at the terminal phase of the disease is a granulocytic hyperplasia. The MPLV isolate replicates in vitro on NIH 3T3 fibroblasts but does not induce foci of transformed cells. Thus, MPLV exhibits unique biological properties that distinguish it either from the Friend virus complexes or from acutely transforming sarcomatogenic murine retrovirus which also induced a rapid splenomegaly.

Entities:  

Mesh:

Year:  1986        PMID: 3004028     DOI: 10.1016/0042-6822(86)90125-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

Review 1.  The molecular mechanisms that control thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 2.  Historical review: megakaryopoiesis and thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  Blood       Date:  2008-02-01       Impact factor: 22.113

Review 3.  Thrombopoietin and platelet development.

Authors:  K Kaushansky
Journal:  West J Med       Date:  1996-03

Review 4.  Polycythemia Vera.

Authors:  Jerry L Spivak
Journal:  Curr Treat Options Oncol       Date:  2018-03-07

5.  Genetic analysis of myeloproliferative leukemia virus, a novel acute leukemogenic replication-defective retrovirus.

Authors:  J F Penciolelli; F Wendling; J Robert-Lezenes; J P Barque; P Tambourin; S Gisselbrecht
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

6.  Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties.

Authors:  M Audit; J Déjardin; B Hohl; C Sidobre; T J Hope; M Mougel; M Sitbon
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin.

Authors:  S Kimura; A W Roberts; D Metcalf; W S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

8.  The human homolog of the myeloproliferative virus maps to chromosome band 1p34.

Authors:  M Le Coniat; M Souyri; I Vigon; F Wendling; P Tambourin; R Berger
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

9.  Gene therapy of MPL deficiency: challenging balance between leukemia and pancytopenia.

Authors:  Daniel C Wicke; Johann Meyer; Guntram Buesche; Dirk Heckl; Hans Kreipe; Zhixiong Li; Karl H Welte; Matthias Ballmaier; Christopher Baum; Ute Modlich
Journal:  Mol Ther       Date:  2009-10-20       Impact factor: 11.454

10.  New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.

Authors:  Ara Metjian; Charles S Abrams
Journal:  Biologics       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.